stakeholders’ workbook exploring vital … here staple here staple here stakeholders’ workbook...

Staple here

Staple here

Staple here

STAKEHOLDERS WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence

CONT I NU I NG TO COMBAT TH E S I L EN T EP I D EM I C OF V I RA L HEPA T I T I S

Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis

Updated 20142016

Developed by the Office of HIV/AIDS and Infectious Disease Policy for planning purposes only

1 STAKEHOLDERS WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence

CON T I N U I N G T O COMB A T T H E S I L E N T E P I D EM I C O F V I R A L H E P A T I T I S

Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis

Updated 20142016

Exploring Vital Roles and Opportunities for Stakeholders

Background Buildingonthesuccessofthenationsfirstcomprehensivecrossagencyactionplan,releasedin2011, Combating the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis,theU.S.Department ofHealth and Human Services(HHS)in collaborationwiththeU.S.DepartmentsofHousingandUrban Development (HUD),Justice(DOJ),andVeteransAffairs(VA) developedandreleased a 3yearupdate ofthat planin April2014.Theupdated ActionPlancontinues topursueitsfouroverarching nationalgoals by 2020:

Increase the proportion ofpersonswhoare aware oftheirHBVinfection from

33percent to66percent,

Increase the proportion ofpersonswhoare aware oftheirHCVinfection from

45percent to66percent,

Reduce the number of new cases ofHCV infectionby25percent,and Eliminate mothertochildtransmissionof HBV.

The updated plandetails morethan 150 actions organized around sixpriorityareasthatagencies andoffices from acrossthefour federaldepartments willpursuebetween 2014 and 2016 to achieve these goals. Theupdated ViralHepatitisActionPlan,orAction Plan,underscoresthatitsnationalgoalscannot beachievedthroughfederalactionalone.Activeinvolvement,andinnovation ofabroadmix ofstakeholdersfromvarioussectors,bot

hpublicandprivate,isessential.S

updateoftheActionPlanandpl

takeholderswerestrongl

nationupdatedpla

algoalnsshoulde forthepreventio

xplicitlyembrayedacriticalrol

cethe

n,diagnosis,care,andtreata

vitalcontributioeinprovidi

nng

mesnoftofviral

input

result,theupdateddocumentcont

variousinto

ainsaninitiallistofopportunitiesthats

hep

ysupportiveofthe

heprocess.Allagreedth atth

stakeht

oldersinachi

e

evingthe

takeholderatitisinth

sfromeUnitedStat

varioussectorses.Asa

canundertaketocompl

ementthefederaleffortsde tailedinthe plan.

Detailing Opportunities for Stakeholders

The plan providesa framework andfocusaroundwhichallkeystakeholderscanengageto strengthenthe nationsresponseto viralhepatitis and seeksto leverageopportunitiestoimprovethe coordinationofviralhepatitisactivitiesacrossallsectors.Thisworkbookwascreatedtoassistyouinidentifyingadditionalinnovativeandactionable (specificand detailed)opportunities toadvanceeachoftheActionPlanssix priorityareas.These may be stepsbyindividualorganizations, actionsthatengageaparticularstakeholdersnetworks,oran entire stateor sectorinactions thatcomplement,amplify,orextendthe actionsdetailedinthe plantowhichthe federalpartnershave committed.Workingtogether,various stakeholders canimprove ournations responseto viralhepatitis and achieve the planslifesavinggoals. Instructions

StakeholderinvolvementisessentialtoensuringtheoverallsuccessoftheActionPlan. Weencourage youandyourcolleaguesto create opportunitiesto talk through ideas,potentialactivities,challenges,tools,resources,andpartnershipsrelatedtoeachpriorityarea. To facilitate discussion,eachpriorityareasectionincludesa brief,simplesummary,thegoalsfromtheActionPlan,sampleopportunities forstakeholders,andinitial discussionquestionsbased onthe goals. Examplesofopportunitiesaredescribedforindividuals,health professionalsandprofessionalorganizations,andcommunitybased,patient,andadvocacygroups.For eachquestion, pleaseidentifythefollowing:

Specificactionsthat you,yourorganization,or otherorganizationscan take to helpimplementthe ActionPlan;

Specificpartnersthatshouldbe engaged;and Keymessagesand/orexisting,effectivemessages.

Atthe end oftheworkbook,wehaveincludedasamplehepatitis planningsheettofurthersupporteffective collaboration.Thesampleplanningsheetprovidesan opportunitytobrainstormtimeframesand measuresfor progress foreachactivity. ThroughimplementationoftheAction Plan,we have foundthat partnershipandcollaborationhavebeen themosteffectivestrategiesto addressviralhepatitis.Werecommendreachingouttoabroadrangeofpotentialpartnersinthepublicandprivatesectors including: departments of health(state andlocal), academicresearchers and programs, community organizationsof allkinds,advocates,professional associations, healthcareprovidergroups,pharmaceutical anddiagnosticscompanies,hospitals,businesses,workforcewellnessprograms,correctionsprograms,andothers. Theideasgeneratedfromthisworkbookcanbesharedwithcolleagueswithinorganizations,workgroupsorcoalitions, communityplanning groups,andotherstakeholderstoidentifyprioritiesandnextstepsto helpguideyourwork. Theaction steps can be used ina variety ofways suchasprogram planning, coalition building,orevenas thetemplateforanAction Plan of yourown.


Priority Area 1: Educating Providers and Communities to Reduce Viral Hepatitisrelated Health Disparities

Confront viral hepatitis by breaking the silence. For too long, there has been silence on viral hepatitis. In order to achieve the goals of the Viral Hepatitis Action Plan, we must work to break this deadly silence on viral hepatitis both among health care providers, as well as other allies working with heavily affected populations, while addressing low levels of awareness of viral hepatitis in the general public.

GOAL 1.1 BuildaU.S.healthcareworkforcepreparedtopreventanddiagnoseviralhepatitisandprovidecareandtreatmenttoinfectedpersons. GOAL 1.2 Decrease healthdisparities by educatingcommunitiesaboutthe benefitsofviralhepatitis prevention,care,andtreatment.

Examples of Opportunities for Stakeholders

Individuals can: Take the CDC Viral HepatitisRiskAssessmentand sharetheAssessmentwithfamily,friends,colleagues,andcommunitymembers.

Askhealthcareprovidersiftestingand/orvaccinationis recommended. Learn more about viral hepatitisand gettested by attendingeventsonNationalHepatitisTesting Day (May 19) andWorld HepatitisDay (July 28).

Medical, nursing, public health and other health professionals and professional organizations, associations, schools and training programs can: Helpdisseminateprofessionaltraining toolsandmaterials. Encourage training of peers and colleagueswithfreeCMEs(such as at www.hepwebstudy.org.) UseCDCs onlineriskassessment todetermine ifclientsneedhepatitisvaccination ortesting. OrderCDCspostersordownload educational fact sheetsforuse withpatients.

Communitybased, patient, and advocacy groups can: UseCDCs hepatitiscampaign materialstohelpspreadtheword about theimportance ofgettingtestedforviralhepatitis.

Holdregular hepatitis testing events,andparticipateinNational Testing Day on May 19th. Continue to buildcoalitionstoexpand theabilitytoreach populationsmostimpactedby

viralhepatitis.


http:www.hepwebstudy.org.)

Priority Area 1EducatingProvidersandCommunities toReduceViralHepatitisrelatedHealthDisparities

Confront viral hepatitis by breaking the silence. What types of training can your organization do and/or promote? What is the most effective format and who are your target audiences? Related Goal: Build a U.S. health care workforce prepared to prevent and diagnose viral hepatitis and provide care and treatment to infected persons (Goal 1.1).

What activities can you conduct to increase community awareness about health disparities in viral hepatitis? Related Goal: Decrease health disparities by educating communities about the benefits of viral hepatitis prevention, care, and treatment (Goal 1.2).

Information, partners, materials, or tools that would be helpful in Priority Area 1 efforts include:


Priority Area 2: Improving Testing, Care, and Treatment to Prevent Liver Disease and Cancer

Take full advantage of existing tools. Providers at every level in the health care system can play a critical role in meeting the needs of the millions of people at risk for and living with viral hepatitis. However, not all providers are prepared to address these needs and missed opportunities to prevent, diagnose, treat, and care for persons with viral hepatitis have resulted in preventable morbidity and mortality. In order to achieve the goals of the Viral Hepatitis Action Plan, we must fully utilize existing training, clinical care tools and policies, address unmet needs, and develop model programs to expand health care provider capacity to provide highquality viral hepatitis prevention, care, and treatment in primary care and other settings.

GOAL 2.1 Identifypersonsinfected withviralhepatitisearly inthe course oftheirdisease. GOAL 2.2 Linkandreferpersonsinfected withviralhepatitistocare and treatment. GOAL 2.3 Improve accesstoand qualityofcare andtreatment forpersons infectedwithviralhepatitis. GOAL 2.4 Advanceresearchtofacilitateviralhepatitispreventionandenhancecare andtreatment forinfected persons.

Opportunities for Stakeholders

Individuals can: Learn about andpromote theCDC ViralHepatitisRiskAssessment anddiscusstheresultant

recommendationswith providers.

Learn about currentantiviraltherapiesandshare theinformationwithchronicallyinfectedfriendsandfamily members.

Medical, nursing, public health and other health professionals and professional organizations, associations, schools and training programs can: Identifyopportunitiesto increaseproviderawarenessand utilizeexistingtraining,tools,and modelprograms. Adoptviralhepatitistestingandcarerecommendationsinclinicalsettings. Ensure followupandlinkageto carewhenconductingviralhepatitistesting.

Communitybased, patient and advocacy groups can: Developculturallyandlinguisticallyrelevanthealthliteracy toolsandmaterialsforpopulationsatriskforhepatitisBandC.

Mobilize communities aboutthe silentepidemic of viralhepatitisandthe threatsof an

unaddressedepidemic.


Priority Area 2 Improving Testing, Care,and TreatmenttoPreventLiver Disease and Cancer

Take full advantage of existing tools. What are the best ways to identify persons with chronic viral hepatitis who do not know they are infected? What can your organization do to promote this? Related Goal: Identify persons infected with viral hepatitis early in the course of their disease (Goal 2.1).

How can your organization effectively link and refer persons diagnosed with viral hepatitis to care and treatment? Related Goal: Link and refer persons infected with viral hepatitis to care and treatment (Goal 2.2).

What activities/strategies could improve access to and quality of care and treatment for persons infected with viral hepatitis? Are there specific activities/strategies for special populations and/or the communities you serve? Related Goal: Improve access to and quality of care and treatment for persons infected with viral hepatitis (Goal 2.3).

Are there ways you can work with researchers to come up with strategies to improve viral hepatitis prevention, care, and treatment? Related Goal: Advance research to facilitate viral hepatitis prevention and enhance care and treatment for infected persons (Goal 2.4).

Information, partners, materials or tools that would be helpful in Priority Area 2 efforts include:

What activities can your organization or other nonfederal partners do to decrease health disparities in viral hepatitis?

Information, materials or tools that would be helpful to have in order to this include:


Priority Area 3: Strengthening Surveillance to Detect Viral Hepatitis Transmission and Disease

Collect accurate and timely information to get the job done. Surveillance and other health data are necessary to shape and direct effective viral hepatitis prevention, care, and treatment efforts. Data can also play an important role in making decisions on how resources can best be allocated to meet the needs of populations at risk for or infected with HBV or HCV. In order to achieve the goals of the Viral Hepatitis Action Plan, partners across various sectors must build new relationships, identify opportunities to utilize HIT, and maximize our use of available data for informed decisionmaking.

GOAL 3.1 Monitorviralhepatitisassociatedhealthdisparities,transmission,anddisease. GOAL 3.2 Monitorprovisionandimpactof viralhepatitisprevention,care, andtreatmentservices. GOAL 3.3 Develop and implement newtechnologiesandlaboratoryprocedurestoimproveviralhepatitissurveillance. Opportunities for Stakeholders

Medical, nursing, and other medical professionals can: Reportviral hepatitisinaccordancewithpublichealthandcommunicablediseaserequirements. Collaboratewithpublichealthauthoritiestoimprovesurveillancedatacompleteness andquality. Useelectronichealth recordtechnologyto assessandevaluate theimpact ofviralhepatitisand relatedservices. Establishpatientregistries toevaluate andimprove patientmanagementand clinicalprocesses.

Public health, research, and other health professionals and professional organizations, associations, schools and training programs can: Develop more detailed informationaboutpopulationspecifichealthdisparitiesinviralhepatitis

prevention,diagnosis, care,andtreatment. Contribute toresearchandthedevelopmentofimprovedtesting proceduresandtechnologies. Supportstatesurveillanceprojects and epidemiologicalinvestigationstohelpunderstandthe characteristicsandneedsof the emerginghepatitisCepidemic amongyoungpeoplewho injectdrugs.

Communitybased, patient and advocacy groups can: Promoteandsupportresearchondeterminingthe prevalence ofhepatitis among homelessand otheratriskindividualsandfamilies.

Developplainlanguagedocuments basedonresearchanddisseminate to communities.


Priority Area 3StrengtheningSurveillancetoDetectViralHepatitisTransmissionandDisease

Collect accurate and timely information to get the job done. How can your program contribute to the monitoring of viral hepatitisassociated health disparities? Related Goal: Monitor viral hepatitisassociated health disparities, transmission, and disease (Goal 3.1).

What opportunities are there for your organization to monitor or provide information about the provision and impact of viral hepatitis prevention, care, and treatment services? Related Goal: Monitor provision and impact of viral hepatitis prevention, care, and treatment services (Goal 3.2).

What new technologies or lab services would improve your ability to serve people living with or at risk for viral hepatitis? Related Goal: Develop and implement new technologies and laboratory procedures to improve viral hepatitis surveillance (Goal 3.3).



Priority Area 4: Eliminating Transmission of VaccinePreventable Viral Hepatitis

Take full advantage of vaccines that can prevent hepatitis A and B. Focused efforts to increase the number of persons who receive hepatitis A and B vaccination will lead to further reductions in the burden of hepatitis A and B in the United States and to the elimination of mothertochild transmission of hepatitis B.

GOAL 4.1 EliminatemothertochildtransmissionofhepatitisB. GOAL 4.2 Achieve universal hepatitis A andBvaccinationfor vulnerable adultsandyouth. GOAL 4.3 Designandtestneworimproved viralhepatitisvaccines,anddeterminetheindicationsfortheiroptimaluse. Opportunities for Stakeholders

Individuals can: AskhealthcareprovidersifvaccinationforHAV and/orHBVis recommendedfortheirparticularhealthcare needs. Request atestforHBV if itsrecommendedby the CDC ViralHepatitisRiskAssessment.

Public health, research, and other health professionals and professional organizations, associations, schools and training programs can: Conducthealthcareproviderand consumer educationon HBVscreening for pregnantwomen andensuringneonatesreceiveabirthdose ofhepatitis Bvaccine. Ensurethatinstitutional policiesincludeHBVscreeningforexpectantwomenandprompt

administrationof the birthdoseof hepatitisBvaccineto infants. Complete the threedose seriesandreceivepostvaccination testingforinfantsborn to HBsAgpositivewomen. Initiate orenhancevaccination inclinicalsettings serving prioritypopulations. Investinresearchonneworimprovedvaccines.

Communitybased, patient and advocacy groups can: Disseminate federally developedrecommendations, guidelines,andcampaign materials to

professional,institutional, consumer,andcommunitynetworks. Collaboratewithpublichealthandcommunitystakeholderstoeducate,screen,andvaccinate

prioritypopulations. Educate the publicandhealthcareprovidersabout thepreventivebenefitsandcoverageprovisionsofthe Affordable Care Act andtheirimplicationsforimproved hepatitisAandB vaccinecoverage.


Priority Area 4Eliminating TransmissionofVaccinePreventableViralHepatitisTake full advantage of vaccines that can prevent hepatitis A and B.

What activities can your organization undertake to raise awareness about and/or reduce perinatal hepatitis B? Related Goal: Eliminate mothertochild transmission of hepatitis B (Goal 4.1).

How can your organization increase hepatitis A and B vaccination rates for vulnerable adults and youth? (May be different for different target audiences AAPI, PWID, others) Related Goal: Achieve universal hepatitis A and B vaccination for vulnerable adults and youth (Goal 4.2).

What can your organization do to support Hepatitis C vaccine development and/or preparedness at the community level? Related Goal: Design and test new or improved viral hepatitis vaccines, and determine the indications for their optimal use. (Goal 4.3)



Priority Area 5: Reducing Viral Hepatitis Associated with Drug Use

Stop the spread of viral hepatitis associated with drug use. A broad crosssection of publicand privatesector partners is increasingly alarmed by the emergence of an epidemic of hepatitis C infection among young people who inject drugs, both male and female, primarily in rural and suburban settings, who started prescription opioid use before transitioning to heroin injection. There is an urgent need for research, surveillance, and prevention strategies that interrupt viral hepatitis transmission in order to curb rising incidence rates in young people and others who use and/or inject drugs.

GOAL 5.1 Ensurethatpersonswho injectdrugshave accessto viralhepatitisprevention,care,and treatment services. GOAL 5.2 Develop and mobilize communityresourcestopreventviralhepatitiscausedbyinjection druguse. GOAL 5.3 Expandaccess toanddeliveryof hepatitisprevention,care,andtreatmentservicesin correctionalsettings. GOAL 5.4 Advanceresearchtoimprovepreventionofviralhepatitisamong personswhouse drugs. Opportunities for Stakeholders Individuals can: Learn the risksof viralhepatitisassociatedwithinjectiondrug useandstrategies toprevent transmission. Share accuratefactsabout viral hepatitiswithfriends,peers, and family members.

Public health, research, and other health professionals and professional organizations, associations, schools and training programs can: Identifysignificant gapsin services,socialsupportsandother needsof PWID atthe communitylevel. Promotetheavailabilityoftrainingopportunitiesforprovidersandotherswhoworkcloselywith

thoseatriskforinitiatinginjectiondrug use,PWID,andpeopleincorrectionalfacilities.

Communitybased, patient and advocacy groups can: Adviseinthe developmentoftrainingtoolsandcurriculaforworkingwith PWID andotherdrug users. Addressthe needsof youngpeopleinfectedwith andaffectedby HCV(since youngPWID may notprioritizehepatitisCprevention,interventionswillneedto holisticallyaddresstheirotherpriorities,focusingon basicneeds andageappropriatehealthcare anddrug treatment, integrating HCV preventioninterventions intothesepointsofcontact).

Collaboratelocallywithpartners fromtheaddictionsandrecoverycommunities,researchers,public healthauthorities,syringeservice programs, opioid substitutionproviders,andotheralliestosupport increasedviralhepatitiseducation and services for peoplewho injectdrugs.


Priority Area 5ReducingViralHepatitisCausedbyDrugUse

Stop the spread of viral hepatitis associated with drug use. What steps can you/your organization take to ensure that persons who inject drugs have access to viral hepatitis prevention, care, and treatment information and services? Related Goal: Ensure that persons who inject drugs have access to viral hepatitis prevention, care, and treatment services (Goal 5.1).

What can you/your organization do to develop and mobilize community resources to prevent viral hepatitis associated with drug use/PWID, especially among young drug users? Related Goal: Develop and mobilize community resources to prevent viral hepatitis caused by injection drug use (Goal 5.2).

What roles can your organization play in expanding the provision of viral hepatitis information and access to and delivery of hepatitis prevention, care, and treatment services in correctional settings? Related Goal: Expand access to and delivery of hepatitis prevention, care, and treatment services in correctional settings (Goal 5.3).

What are the opportunities for you/your organization to work with researchers and communities to develop/implement strategies to improve prevention of viral hepatitis among persons who use drugs? Related Goal: Advance research to improve prevention of viral hepatitis among persons who use drugs (Goal 5.4).



Priority Area 6: Protecting Patients From Health CareAssociated Viral Hepatitis

Quality health care is safe health care. Neither patients nor providers should be at risk for acquiring HBV, HCV, or other bloodborne infections during health care encounters. Stakeholders in the Action Plan recognize that such health careassociated infections are an important public health and patient safety issue and are committed to better understanding the causes and further reducing the risk of their occurrence.

GOAL 6.1 Reducetransmissionof viralhepatitistopatientsresultingfrom misuse of medicaldevicesanddrugs. GOAL 6.2 Reducetransmissionof viralhepatitis associatedwithblood,organs,andtissues. GOAL 6.3 Reduceoccupationaltransmissionof viralhepatitis. GOAL 6.4 Enhanceunderstandingofthepreventablecausesof viralhepatitistransmissionin healthcaresettings. Opportunities for Stakeholders Individuals can: Askhealthcareprovidersifa newneedle,newsyringe, anda newvialwillbeusedfor proceduresorinjections. Askhealthcareprovidershowtheyprevent the spreadof infectionsintheirfacilities.

Public health, research, and other health professionals and professional organizations, associations, schools and training programs can: Ensureinstitutional infectioncontrolandprevention policies are updated, clearlycommunicated, andenforced.

Updateandconductprovidertrainings ininfectioncontrol. Investinnewtechnologiesthat reducetransmissionof bloodbornepathogens. Vaccinateallhealthcareworkersfor hepatitisB. Implement measuresto prevent opioiddiversion. Developnew resources,tools,and technologiesthatreducethe likelihoodof health careassociated diseasetransmission.

Conductresearchtoidentifytransmissionrisksandguidethedevelopment of improvedprocedures, policies,andpractices.

Communitybased, patient and advocacy groups can: Disseminaterecommendations,guidelines,andcampaign materials toprofessionaland

institutional networks. Reportsuspectedhealthcareassociatedoutbreaksandcollaboratewithpublichealthinvestigationandresearchefforts.


Priority Area 6 Protecting Patientsand Workers FromHealthCareAssociated ViralHepatitis

Quality health care is safe health care. How can you/your organization contribute to reducing the transmission of viral hepatitis to patients in medical settings and raise awareness about this issue? Related Goal: Reduce transmission of viral hepatitis to patients resulting from misuse of medical devices and drugs (Goal 6.1).

What can your organization do to promote viral hepatitis testing and awareness among potential blood, organ, and tissue donors? Related Goal: Reduce transmission of viral hepatitis associated with blood, organs, and tissues (Goal 6.2).

What opportunities do(es) you/your organization have to raise awareness about viral hepatitis prevention in health care and other occupational settings? Related Goal: Reduce occupational transmission of viral hepatitis (Goal 6.3).

What activities/strategies can you/your organization promote or support to better understand the preventable causes of viral hepatitis transmission in health care settings? Related Goal: Enhance understanding of the preventable causes of viral hepatitis transmission in health care settings (Goal 6.4).

Information, partners, materials or tools that would be helpful in Priority Area 6 include:



Hepatitis Activity Planning Sheet: Please use the chart below to plan activities for your organization as they relate to Priority Areas 16.

Priority Area __:

GOAL Proposed Activity Lead Staff Potential Partners Initiation

Date

Anticipated Completion

Date Possible Measures

GOAL __ [Describe activity] [Add staff names] [Add partners list] mm/dd/yy mm/dd/yy [Describe measure]





Make additional copies of this table as needed for activities in each Priority Area.

NOTES


STAKEHOLDERS WORKBOOK Exploring Vital Roles and Opportunities to Break the Silence

Developed by the Office of HIV/AIDS and Infectious Disease Policy for planning purposes only

STAKEHOLDERS WORKBOOK Exploring Vital Roles and Opportunities to Break the SilenceAction Plan for the Prevention, Care,& Treatment of Viral HepatitisUpdated 20142016Exploring Vital Roles and Opportunities for StakeholdersDetailing Opportunities for StakeholdersPriority Area 1: Educating Providers and Communities to Reduce Viral Hepatitisrelated Health DisparitiesPriority Area 2: Improving Testing, Care, and Treatment to Prevent Liver Disease and CancerPriority Area 3: Strengthening Surveillance to Detect Viral Hepatitis Transmission and DiseasePriority Area 4: Eliminating Transmission of VaccinePreventable Viral HepatitisPriority Area 5: Reducing Viral Hepatitis Associatedwith Drug UsePriority Area 6: Protecting Patients From Health CareAssociated Viral HepatitisHepatitis Activity Planning Sheet: Please use the chart below to plan activities for your organization as they relate to Priority Areas 16.NOTES

What are the best ways to identify persons with chronic viral hepatitis who do not know they are infected What can your organization do to promote this Related Goal Identify persons infected with viral hepatitis early in the course of their disease Goal 21: How can your organization effectively link and refer persons diagnosed with viral hepatitis to care and treatment Related Goal Link and refer persons infected with viral hepatitis to care and treatment Goal 22: What activitiesstrategies could improve access to and quality of care and treatment for persons infected with viral hepatitis Are there specific activitiesstrategies for special populations andor the communities you serve Related Goal Improve access to and quality of care and treatment for persons infected with viral hepatitis Goal 23: Are there ways you can work with researchers to come up with strategies to improve viral hepatitis prevention care and treatment Related Goal Advance research to facilitate viral hepatitis prevention and enhance care and treatment for infected persons Goal 24: Information partners materials or tools that would be helpful in Priority Area 2 efforts include: What activities can your organization or other nonfederal partners do to decrease health disparities in viral hepatitis: Information materials or tools that would be helpful to have in order to this include: Activities: organization increase: organization to do: Informtion partners materials: Program contribute: Opportunities: New Technologies: Information: Promote: Awareness: Types of Training: What steps can youyour organization take to ensure that persons who inject drugs have access to viral hepatitis prevention care and treatment information and services Related Goal Ensure that persons who inject drugs have access to viral hepatitis prevention care and treatment services Goal 51: What can youyour organization do to develop and mobilize community resources to prevent viral hepatitis associated with drug usePWID especially among young drug users Related Goal Develop and mobilize community resources to prevent viral hepatitis caused by injection drug use Goal 52: What roles can your organization play in expanding the provision of viral hepatitis information and access to and delivery of hepatitis prevention care and treatment services in correctional settings Related Goal Expand access to and delivery of hepatitis prevention care and treatment services in correctional settings Goal 53: What are the opportunities for youyour organization to work with researchers and communities to developimplement strategies to improve prevention of viral hepatitis among persons who use drugs Related Goal Advance research to improve prevention of viral hepatitis among persons who use drugs Goal 54: Information partners materials or tools that would be helpful in Priority Area 5 efforts include: How can youyour organization contribute to reducing the transmission of viral hepatitis to patients in medical settings and raise awareness about this issue Related Goal Reduce transmission of viral hepatitis to patients resulting from misuse of medical devices and drugs Goal 61: What can your organization do to promote viral hepatitis testing and awareness among potential blood organ and tissue donors Related Goal Reduce transmission of viral hepatitis associated with blood organs and tissues Goal 62: What opportunities does youyour organization have to raise awareness about viral hepatitis prevention in health care and other occupational settings Related Goal Reduce occupational transmission of viral hepatitis Goal 63: What activitiesstrategies can youyour organization promote or support to better understand the preventable causes of viral hepatitis transmission in health care settings Related Goal Enhance understanding of the preventable causes of viral hepatitis transmission in health care settings Goal 64: Information partners materials or tools that would be helpful in Priority Area 6 include: GOAL: Describe activity: Add staff names: Add partners list: mmddyy: mmddyy_2: Describe measure: GOAL_2: Describe activity_2: Add staff names_2: Add partners list_2: mmddyy_3: mmddyy_4: Describe measure_2: GOAL_3: Describe activity_3: Add staff names_3: Add partners list_3: mmddyy_5: mmddyy_6: Describe measure_3: GOAL_4: Describe activity_4: Add staff names_4: Add partners list_4: mmddyy_7: mmddyy_8: Describe measure_4: GOAL_5: Describe activity_5: Add staff names_5: Add partners list_5: mmddyy_9: mmddyy_10: Describe measure_5: NOTESRow1:

stakeholders’ workbook exploring vital … here staple here staple here stakeholders’ workbook...

Documents